Skip to main content

Inogen Inc

corporate_fare Company Profile

Inogen Inc

INGN·NASDAQ·Industrial Applications And Services·CIK 0001294133

Inogen, Inc. is a medical technology company focused on respiratory health. The company develops, manufactures, and markets respiratory health products, including portable oxygen concentrators (POCs) and the Simeox® product for airway clearance treatment. Inogen, Inc. has also begun distributing the Inogen Voxi® 5 stationary oxygen concentrator and Aurora® continuous positive airway pressure (CPAP) masks in the United States. The proprietary Inogen One® and Inogen Rove® POC systems concentrate ambient air to provide supplemental oxygen 24 hours a day, seven days a week, using a battery or by plugging into an outlet. These POCs aim to reduce patient reliance on stationary oxygen concentrators and scheduled deliveries of oxygen tanks. The Simeox product is a technology-enabled mucus management device primarily for patients requiring airway clearance, such as those with bronchiectasis, cystic fibrosis, chronic obstructive pulmonary disease (COPD), or other chronic respiratory diseases. The Voxi 5 stationary oxygen concentrator provides continuous, long-term oxygen therapy for patients needing supplemental oxygen at home or in clinical settings. Aurora CPAP masks are used with a separate device to deliver CPAP therapy, mainly for treating obstructive sleep apnea (OSA). Inogen, Inc. was incorporated in Delaware on November 27, 2001. The company completed an initial public offering on February 14, 2014, and its common stock began trading on the Nasdaq Global Select Market under the ticker symbol "INGN". Inogen Europe Holding B.V., a Dutch limited liability company, was incorporated on April 13, 2017.

Inogen Inc (NASDAQ:INGN) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors INGN SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Stockholders Approve Equity Plan Expansion, Reject Board Declassification
  • Inogen Reports Wider Q1 Net Loss and Negative Adjusted EBITDA Despite Revenue Growth
  • Inogen's Q1 Revenue Jumps 3.4% to Beat Estimates, Driven by International Demand
  • Inogen Reports Q1 Revenue Beat, But Profitability Declines; Reaffirms Full-Year Guidance
  • Inogen Proposes Significant Equity Plan Increase and Board Declassification at Annual Meeting

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$348.67M
Net Income
-$22.75M
Diluted EPS
-$0.86
Op. Cash Flow
-$11.22M
Free Cash Flow
-$13.74M
Gross Profit
$154.26M
Operating Income
-$30.21M
Cash & Equivalents
$103.73M
Debt / Equity
0.00×
Net Margin
-6.5%
Shares Outstanding
27.23M sh
Source: 10-K · filed 2026-02-27 · accession 0001193125-26-082630
Browse all tickers starting with I →
$6.4
52-week range · as of 2026-06-11 $5.34 – $9.13
Market cap
$173.28M
Volume
148.4K (0.4× avg)
3-mo avg 383.7K
Live data · 2026-06-14 06:08 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed INGN - Latest Insights

INGN
Jun 11, 2026, 4:32 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.13
Real-time Price: $6.40 info
Change: +$0.270 (+4%) info
Market Cap: $173.277M info
INGN
May 08, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.02
Real-time Price: $6.40 info
Change: -$0.620 (-9%) info
Market Cap: $173.277M info
INGN
May 07, 2026, 4:47 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $7.05
Real-time Price: $6.40 info
Change: -$0.650 (-9%) info
Market Cap: $173.277M info
INGN
May 07, 2026, 4:13 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.05
Real-time Price: $6.40 info
Change: -$0.650 (-9%) info
Market Cap: $173.277M info
INGN
Apr 28, 2026, 4:09 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $7.35
Real-time Price: $6.40 info
Change: -$0.950 (-13%) info
Market Cap: $173.277M info
INGN
Apr 17, 2026, 4:06 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $6.82
Real-time Price: $6.40 info
Change: -$0.420 (-6%) info
Market Cap: $173.277M info
INGN
Apr 06, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.36
Real-time Price: $6.40 info
Change: +$0.040 (+0.63%) info
Market Cap: $173.277M info
INGN
Mar 30, 2026, 5:32 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.11
Real-time Price: $6.40 info
Change: +$0.290 (+5%) info
Market Cap: $173.277M info
INGN
Feb 27, 2026, 4:12 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $6.10
Real-time Price: $6.40 info
Change: +$0.300 (+5%) info
Market Cap: $173.277M info
INGN
Feb 24, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $6.22
Real-time Price: $6.40 info
Change: +$0.180 (+3%) info
Market Cap: $173.277M info